Td Ameritrade Investment Management, LLC Genmab A/S Transaction History

Td Ameritrade Investment Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$35.27 - $42.24 $79,498 - $95,208	-2,254 Closed	0 $0
Q2 2023 Aug 09, 2023	SELL	$37.4 - $42.94 $4,749 - $5,453	-127 Reduced 5.33%	2,254 $86,000
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $20,404 - $25,283	-585 Reduced 19.72%	2,381 $90,000
Q4 2022 Feb 09, 2023	SELL	$33.8 - $47.06 $29,642 - $41,271	-877 Reduced 22.82%	2,966 $126,000
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $11,851 - $140,477	-376 Reduced 8.91%	3,843 $123,000
Q2 2022 Aug 09, 2022	SELL	$26.83 - $38.57 $18,190 - $26,150	-678 Reduced 13.85%	4,219 $137,000
Q1 2022 May 16, 2022	SELL	$30.95 - $39.68 $10,646 - $13,649	-344 Reduced 6.56%	4,897 $177,000
Q4 2021 Feb 11, 2022	BUY	$35.87 - $47.12 $77,945 - $102,391	2,173 Added 70.83%	5,241 $207,000
Q3 2021 Nov 12, 2021	SELL	$41.55 - $48.72 $59,998 - $70,351	-1,444 Reduced 32.0%	3,068 $112,000
Q2 2021 Aug 16, 2021	BUY	$32.88 - $44.57 $29,427 - $39,890	895 Added 24.74%	4,512 $184,000
Q4 2020 Feb 10, 2021	BUY	$33.66 - $40.76 $18,479 - $22,377	549 Added 17.89%	3,617 $147,000
Q3 2020 Nov 13, 2020	BUY	$33.07 - $38.68 $10,714 - $12,532	324 Added 11.81%	3,068 $112,000
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $5,373 - $9,082	268 Added 10.82%	2,744 $93,000
Q1 2020 May 13, 2020	SELL	$17.15 - $25.22 $171 - $252	-10 Reduced 0.4%	2,476 $52,000
Q4 2019 Feb 07, 2020	BUY	$18.88 - $24.14 $18,842 - $24,091	998 Added 67.07%	2,486 $56,000
Q3 2019 Nov 07, 2019	BUY	$18.0 - $21.38 $26,784 - $31,813	1,488 New	1,488 $30,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.